Pancreas Center & Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Langenbecks Arch Surg. 2022 Aug;407(5):2161-2168. doi: 10.1007/s00423-021-02382-8. Epub 2022 May 24.
Portal vein/superior mesenteric vein (PV/SMV) resection during distal pancreatectomy (DP) is often associated with technical difficulties due to the close anatomic relationship between pancreatic head and PV/SMV. In this paper, we present our operative technique and short-term outcomes of DP combined with venous resection (DP-VR) for left-sided pancreatic cancer (PC).
We reviewed 368 consecutive cases of DP for PC from January 2013 to December 2018 in our institution, and identified 41 patients (11.1%) who had undergone DP-VR. The remaining 327 DP patients (88.9%) were matched to DP-VR using propensity scores in the proportion of 1:2. Demographics, intraoperative details, postoperative complications and the pathological results were compared between the two groups.
Out of the 41 DP-VR cases, in 14 (34.1%) venous resection with primary closure was performed, while the remaining 27 (65.9%) underwent end-to-end anastomosis without graft. A propensity-score-matched analysis revealed that DP-VR caused an increased risk of postoperative bleeding (17.1% vs. 3.7%, P = 0.016) and delayed gastric emptying (9.8% vs. 1.2%, P = 0.042) compared to standard DP. Overall morbidity (46.3% vs. 36.6%, P = 0.332), postoperative pancreatic fistula (31.7% vs. 26.8%, P = 0.672), R0 resection (58.5% vs. 67.1%, P = 0.223), 30-day reoperation (2.4% vs. 3.7%, P = 0.719), and 90-day mortality (0% vs. 2.5%, P = 0.550) were comparable between the two groups. In postoperative computed tomographic scans of 34 patients (82.9%) at a 90-day follow-up, PV/SMV stenosis was suggested in two patients (5.9%).
Despite the higher rates of postoperative bleeding, DP-VR was found to be a feasible and safe surgery with acceptable postoperative morbidity and mortality compared to standard DP for left-sided pancreatic cancer.
远端胰腺切除术(DP)过程中门静脉/肠系膜上静脉(PV/SMV)的切除常常由于胰腺头部与 PV/SMV 之间的紧密解剖关系而存在技术难度。本文中,我们展示了我们在左侧胰腺癌(PC)中实施 DP 联合静脉切除(DP-VR)的手术技术和短期结果。
我们回顾了 2013 年 1 月至 2018 年 12 月我院连续 368 例 DP 治疗 PC 的病例,其中 41 例(11.1%)患者接受了 DP-VR。其余 327 例 DP 患者(88.9%)采用倾向评分进行 1:2 比例匹配,以接受 DP-VR。比较两组患者的人口统计学资料、术中细节、术后并发症和病理结果。
41 例 DP-VR 中,14 例(34.1%)行静脉切除+一期缝合,27 例(65.9%)行端端吻合而无需移植物。倾向评分匹配分析显示,与标准 DP 相比,DP-VR 增加了术后出血(17.1% vs. 3.7%,P=0.016)和胃排空延迟(9.8% vs. 1.2%,P=0.042)的风险。总体发病率(46.3% vs. 36.6%,P=0.332)、术后胰瘘(31.7% vs. 26.8%,P=0.672)、R0 切除(58.5% vs. 67.1%,P=0.223)、30 天再手术(2.4% vs. 3.7%,P=0.719)和 90 天死亡率(0% vs. 2.5%,P=0.550)在两组间无差异。34 例(82.9%)患者在术后 90 天的 CT 扫描中提示 2 例(5.9%)存在 PV/SMV 狭窄。
尽管术后出血发生率较高,但与标准 DP 相比,DP-VR 是一种可行且安全的手术,其术后发病率和死亡率可接受。